Product Images Ezetimibe And Simvastatin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Ezetimibe And Simvastatin NDC 60429-880 by Golden State Medical Supply, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

60429 879 30LB

60429 879 30LB

This is a medication for reducing cholesterol levels in patients. The medication name is Ezetimibe & Simvastatin and comes in a 10 mg/10 mg dosage. The tablet packaging contains 30 tablets, and dosage information is included in the package insert. The medication should be stored between 20°C to 25°C. Each tablet contains 10 mg of both ezetimibe and simvastatin. The medication should be kept out of reach of children and in a tightly closed container with a child-resistant closure. The medication is manufactured by Teva Pharmaceutical Industries Ltd in Israel and packaged by GSMS Incorporated in Camarillo, California.*

60429 880 30LB

60429 880 30LB

This medication contains ezetimibe and simvastatin and comes in tablet form. Each tablet contains 10mg of ezetimibe and 20mg of simvastatin. It is important to store this medication at a temperature between 20°C to 25°C (68°F to 77°F) in a package that includes further information. Dispense with the accompanying patient information leaflet and keep it out of the reach of children. The medication should be kept in a tightly closed light-resistant container and dispensed as needed. The manufacturer is Tova Pharmaceutical Ind. Ltd., located in Jerusalem, Israel while the medication is packaged by GSMS, Incorporated in Camarillo, CA, USA.*

60429 881 30LB

60429 881 30LB

This is a package of EZETIMIBE & SIMVASTATIN TABLETS containing 10 mg/40 mg. The tablets come in a container that needs to be stored at a temperature between 20° to 25°C (88° to 77°F). Each tablet contains 10 mg of ezetimibe and 40 mg of simvastatin, and the package should include patient information leaflet when being dispensed. The container should also be kept tightly closed and away from the reach of children. The manufacturer is Teva Pharmaceuticals, located in Camarillo, CA 93012 USA.*

60429 882 30

60429 882 30

The text is a description of a medication called Ezetimibe & Simvastatin tablets, each tablet containing 10 mg ezetimibe and 80 mg simvastatin. It includes the NDC code and directions to store the medication at 20° to 25°C (68° to 77°F). It also advises to keep the medication out of the reach of children, keep the container tightly closed, and dispense in a light-resistant container with a child-resistant closure. The manufacturer is Teva Pharmaceutical Ind. Lid. of Jerusalem, Israel, and the medication is packaged by GSMS, Incorporated of Camarillo, CA 93012 USA.*

ezetimibe structural formula - image 01

ezetimibe structural formula - image 01

simvastatin structural formula - image 02

simvastatin structural formula - image 02

Figure 1: Effect of Ezetimibe and Simvastatin on the Primary Endpoint of Risk of Major Vascular Events - image 03

Figure 1: Effect of Ezetimibe and Simvastatin on the Primary Endpoint of Risk of Major Vascular Events - image 03

This appears to be a graph representing the percentage of patients with major vascular events over several years of follow-up for two different treatment groups: placebo and a combination of ezetimibe and simvastatin. The x-axis appears to show the years of follow-up, while the y-axis shows the percentage of patients with major vascular events. However, without more context, it is unclear what the study being referenced here is.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.